Abstract
Objective: Bone morphogenetic proteins (BMPs) are members of the transforming growth factor β (TGF β) superfamily. BMP2, BMP5 and BMP10 exert their biological functions by interacting with membrane bound receptors belonging to the serine/threonine kinase family. Hirschsprung disease (HSCR) is characterized by the absence of intramural ganglion cells in the nerve plexuses of the distal gut. However, putative Notch function in enteric nervous system (ENS) development and the etiology of HSCR is unknown. Methods: Aganglionic and ganglionic colon segment tissues of 50 HSCR patients were investigated for the expression pattern of BMP2, BMP5 and BMP10 using real-time RT-PCR, Western blot analysis and immunohistochemical staining. Results: The mRNA levels of BMP2, BMP5 and BMP10 in the stenotic colon segment from HSCR patients were significantly higher than those in the normal ones. Similar increased expressions of them in the stenotic colon segments were detected by Western blotting coupled with densitometry analysis. Lastly, immunohistologicl stain showed significant BMP2, 5 and 10 increases in mucous and muscular layers from stenotic colon segments compared to normal segments. Conclusions: BMP2, BMP5 and BMP10 are elevated in the stenotic colon segment of HSCR, and BMPs signaling plays a pivotal role in the development of HSCR.
Keywords: Bone morphogenetic proteins (BMPs), Hirschsprung disease (HSCR), enteric nervous system (ENS), stenotic colon, ganglion cell
Introduction
Hirschsprung disease (HSCR) is a common congenital intestinal defect in children, characterized by absence of focal intestinal ganglion cells. HSCR represents the main genetic cause of functional intestinal obstruction with an average incidence of 20/100,000 live births worldwide. Males are affected four times more often than females (a difference most prominent in short segment HSCR). There is a significant racial variation in the incidence of the disease and it is most often found among Asians (28 per 100,000 live births) [1]. Its main cause is that ganglion cells cannot cluster and locate in the intestinal wall. Genetic predisposition and intestinal microenvironment changes may contribute to development of HSCR. Nevertheless, the etiology and pathogenesis of HSCR are still incompletely understood. Symptoms in infants include difficult bowel movements, poor feeding, poor weight gain, and progressive abdominal distention. The early diagnosis of HSCR is often challenging, because no more than 10% of HSCR cases have a late presentation with classical chronic constipation and megacolon [2]. Therefore, effective tools or related genes for further understanding of HSCR are urgently needed.
Enteric nervous system (ENS) derived from migratory neural crest is the largest subdivision of the peripheral nervous system to regulate the gut behaviors, including the coordination of the smooth muscle contractions of the gut wall. The ENS neurons and glia cells organized into ganglia, which are interconnected to form two types of plexuses: the submucosal (Meissner’s) and the myenteric (Auerbach’s) plexus between the longitudinal and circular smooth muscle layers [3]. To date, at least 11 genes have been associated with sporadic or syndromic forms of HSCR. These ‘HSCR genes’ are generally related to the developmental program of neural crest cells, and include the RET Proto-oncogene, glial cell line-derived neurotrophic factor (GDNF), neurturin (NTN), endothelin3 (EDN3), endothelin receptor B (EDNRB), endothelin converting enzyme l (ECE1), transcriptional factors SOX10 and PHOX2B, ZFNX1B, KIAA1279, and TITF1 [4,5].
Recent studies showed that bone morphogenetic protein (BMP) signaling has been proven to play a continuing role in the maintenance and function of neuronal cells in the ENS [6]. Several studies have demonstrated that BMP2 and BMP5 were highly expressed in colon tops, and BMP10 has been associated with inflammatory bowel disease (IBD) [7]. However, direct demonstration of BMPs expression in human tissues is few and is restricted to tumor samples. In this study, colon tissue samples from HSCR patients are examined for the expression of BMP2, BMP5 and BMP10, and significant increase of BMP2, BMP5 and BMP10 was detected in HSCR compared to normal colon tissues, suggesting that BMP signaling pathway plays a crucial role in the development of HSCR.
Materials and methods
Patients and specimens
Both stenotic and normal tissue samples were obtained from 50 HSCR patients. The patients ranged from 0.5 to 3.1 years old with an average of 1.5-years including 33 males and 17 females. Based on the results of barium enema and the intestinal morphology during and after the operation, the surgical specimens were divided into stenotic colon segments and normal colon segments, which were further confirmed by histological examination of the frozen section of each segment. The stenotic colon segments were defined by loss of the focal colonic ganglion cells by H&E stain. HSCR patients received definite pull-through operation at Shengjing Hospital of China Medical University, with adequate informed consent was signed by patients’ supervisor. The study was approved by the local Institutional Research Board. ALL tissue samples were stored at -80°C immediately after operation.
Antibodies
Polyclonal anti-BMP2 and anti-BMP5 antibodies were purchased from Beijing biosynthesis biotechnology co., LTD (Rabbit anti-BMP2 antibody-BMP5 protein, Catalog Number: bs-1012R and bs-6614R). Polyclonal anti-BMP10 antibody was purchased from ABgent (catalog ## AP1710a).
RNA extraction, reverse transcription and quantitative real-time RT-PCR
Approximately 100 mg tissues from stenotic and normal intestines were used for total RNA extraction using RNA extraction reagent TRIZOL (Invitrogen Life Technologies), according to manufacturer’s instructions. The harvested RNA was diluted to a concentration of 1 μg/μl, aliquoted and stored at -80°C. For cDNA synthesis, 1 μg of total RNA was incubating with reverse transcriptase (Superscript™ IIRnase H-Reverse Transcriptase). Quantitative RT-PCR was performed in triplicate for each specimen in the presence of SYBR green PCR Master Mix; (TaKaRa Biotechnology Co.) in a LightCycler (Roche Molecular Biochemicals, Co.). The primers used were listed in Table 1. The amplification process was followed by a melting curve analysis, ranging from 50 to 90°C, with temperature increasing steps of 0.2°C every 10 s. The threshold cycle (CT value) was recorded. To estimate the magnitude of the difference in expression for the individual samples, ΔCT is defined as CTgene of interest minus CTGAPDH and the ΔΔCT (=ΔCTHD samples - ΔCTcontrol samples) was transformed to 2-ΔΔCT as the trend of gene expression level in stenotic colon.
Table 1.
Primer sequences for real-time PCR
Gene name | Sequence (5′-3′) | Annealing temperature (°C) | Amplicon (bp) |
---|---|---|---|
BMP-2 | F GCC TGC TTC GCC ATC T | 55 | 123 |
R TGC CTC CTC CTT CTC CC | |||
BMP5 | F CGC ATA CAG TTA TCT CG | 50 | 160 |
R CTT TGT AAT GCC TTC G | |||
BMP-10 | F AGC TGG ACA ACT TGG G | 51 | 116 |
R TTT GGC GTT CCT TCT G | |||
GAPDH | F AGA GCT ACG AGC TGC CTG AC | 57 | 184 |
R AGC ACT GTG TTG GCG TAC AG |
Hematoxylin and eosin staining and immunohistochemical staining
Immunohistochemical staining was performed as described. The stenotic and normal segment were immediately washed in cold phosphate buffered saline (PBS; pH 7.4), then fixed in 4% buffered paraformaldehyde at 4°C for 24 h. The samples were dehydrated, embedded in paraffin, and sectioned sagittally at a thickness of 4 μm. Slides were then incubated in boiling 0.01 mol/L citrate buffer (pH 6.0) for 10 minutes, cooled at room temperature, incubated with 3% H2O2 for 15 min, and 10% normal goat serum for 30 min. The sections were then incubated with primary anti-BMP2, BMP5 and BMPR10 (1:50) at 4°C for 14 to 16 hours; slides washed in PBS, incubated with anti-rabbit IgG-peroxidase antibody for 20 minutes at room temperature and stained with 3′3-diaminbezidine tetrahydrochloride (DAB). Dark brown granules in the cytoplasm and cytomembrane were considered as positive results. Negative controls were performed by incubating with equivalent concentrations of nonimmune rabbit antiserum. By integrated optical density (IOD) measurement [4], pictures were taken on color-positive films under the same illuminating setting for each sample. The optical density of the cells was measured in the microscopic fields of the seen malformed portion of the sample in cloaca or rectum tissue and the control tissues in those same fields, with a NISE Elements Basic Research (version 2.30) (NIS-Elements Basic Research, Kawasaki, Kanagawa, Japan) analysis system. Two researchers independently reviewed the immunohistochemical-stained slides.
Western blot analysis
Approximately 100 mg specimen was minced to small pieces using surgical blades and sonicated in protein lysis buffer. Protein concentrations were measured by the Bradford method, and specimens were adjusted to the same protein concentration, aliquoted and stored at -80°C. Equal amounts of total proteins from tissues were separated on SDS-polyacrylamide gels and then electro-transferred to PVDF membranes (Millipore, USA). The blots were incubated with following polyclonal antibodies: anti-BMP2, anti-BMP5 and anti-BMP10 (1:100, Beijing biosynthesis biotechnology co., LTD.) overnight at 4°C; washed, incubated with horseradish peroxidase-linked secondary antibodies (1:2000) for 1 h at room temperature and detected using an enhanced chemiluminescence (ECL) kit.
Statistical analysis
The Statistical Program for Social Sciences, version 16.0 (SPSS, Chicago, IL), was used for statistical analysis. Paired T test was used to compare the BMP2, BMP5 and BMP10 expression level between stenotic colon segments and normal colon segments.
Results
Real time quantitative PCR results
The concentration and purity of extracted total RNA from 50 pairs of HSCR patients were determined as the 260/280 ratio by NanoVue-Health care Bio-Sciences AB. Real time RT-PCR was performed and the expression level of BMP2, 5 and 10 was normalized to the mRNA level of GAPDH from the same specimen. Increased expression of BMP2, 5 and 10 were detected in stenotic colon segments from 50 HSCR patients respectively, compared to matched normal colons. By statistical analysis with SPSS 16.0 software, the expressions of BMP2, 5 and 10 in stenotic colon segments were significantly higher than those in normal colons (P<0.05). The mRNA level of BMP2, BMP5 and BMP10 in the stenotic colon segment from HSCR patients were significantly higher (953.0117, 31.83095 and 1596.147 times, separately) than those in the normal colon segments (p<0.05, Figure 1).
Figure 1.
BMP2, BMP5 and BMP10 genes expression analysis by real time PCR of 2 groups. The results were expressed as the mean ± SD, where P<0.05 was considered significance. Data were normalized by the expression level of GAPDH. Significant differences in stenotic colon were observed from corresponding controls.
Western blot analysis
BMP2, BMP5 and BMP10 protein expression in the same group of 50 HSCR patients was evaluated by western blotting with specific antibodies. Consistent with the RT-PCR results, significant increase of BMP2, BMP5 and BMP10 was detected in stenotic colon segment compared to the matched normal colons (Figures 2, 3 and 4).
Figure 2.
BMP2, BMP5 and BMP10 expression in HSCR by Western blot analyses. Data were normalized by the expression level of β-actin. Protein extracts from normal colon segment and stenotic colon segment in HSCR were probed by Western blot analysis with BMP2, BMP5 and BMP10 antibodies
Figure 3.
BMP2, BMP5 and BMP10 genes expression analysis by Western blot analyses. The results were expressed as the mean ± SD, where P<0.05 was considered significance. By statistical analysis with paired T test, the expressions of BMP2, 5 and 10 in stenotic colon segments were significantly higher than those in normal segments (P<0.05).
Figure 4.
BMP2, BMP5 and BMP10 genes expression analysis by normal-stenotic diagram. Data from 50 patients was shown separately. BMP2, BMP5 and BMP10 genes expression level is significantly up-regulated in the stenotic colon.
Immunohistochemistry results
The increased expression of BMP2, BMP5 and BMP10 was further confirmed by immunohistochemistry analyses. The stenotic colon segments were defined by absence of the focal colonic ganglion cells by H&E stain (Figure 5). Of 50 cases of HSCR with BMP increase by RT-PCR and western blot, all of them had positive stains by immunohistochemical stain, which were mainly located in the mucous layer and muscular layer of aganglionic colon segment and appeared as light brown and brown particles (Figure 6).
Figure 5.
Photomicrographs of stenotic and normal intestine. A: Stenotic colon segment tissue (hematoxylin and eosin [H&E], ×400, aganglionic cell); B: Normal colon segment tissue (H&E, ×400, ganglionic cell).
Figure 6.
Expression of BMP2, BMP5 and BMP10 in stenotic and normal colon segment tissue detected by immunohistochemistry (original magnification×400).
Discussion
It is well-known that the onset of HSCR involves a series of complicated process including the distortion of ganglion cell development at different stages, and is caused by multiple factors [2,5]. This developmental disorder is a neurocristopathy and is characterized by the absence of the intestinal ganglion cells of the nerve plexuses in variable lengths of the digestive tract. The cause of the arrest of the crest cells has not been clearly defined. Up to 50% familial and 15-35% sporadic cases could be explained by RET gene mutations excluding other genes [8].
In this study, the stenotic and normal tissue samples were obtained from 50 HSCR patients, which were ranged from 0.5 to 3.1 years old and included 33 males and 17 females (approximately 2:1 male to female ratio). The stenotic segments were identified as that in absence of the focal colonic ganglion cells by H&E staining; in contrast, the normal segments from the same patients were determined with the colonic ganglion cells. Due to that the stenotic segment and the normal segment were compared from the same patient, the paired T-tests were performed during the statistical analysis, although as heathy control, the children volunteers were hardly acquired.
BMPs belong to the transforming growth factor-β (TGF-β) superfamily and have been widely recognized as important molecules involved in tissue differentiation and functional modulation of various endocrine systems [9]. Currently, there are 21 known members in the human BMP family (BMP2-BMP7, BMP8A/B, BMP10, BMP15, GDF1-3, GDF5-7, myostatin, GDF911 and GDF-15 [10]. BMPs, some of which are called growth and differentiation factors (GDF), are dimeric molecules composed of two identical monomers linked with a disulfide bond [11-14]. BMP functions by binding to their receptors, namely, BMPRI (BMPRIA and BMPRIB) and BMPRII, which are located on chromosomes 10q23, 4q22-24, and 2q33-34. BMPRIA mediates growth stimulation signals, and BMPRIB transfers growth inhibition signals [15]. BMP bind to two separate transmembrane serine-threonine kinase receptors, type I and type II, forming a heterotetrameric complex. In the complex, type II receptor phosphorylates and activates the type I receptor that in turn phosphorylates and activates cytosolic Smad proteins. Smad1 complexes with Smad4, and this heterodimeric complex then translocates to the nucleus, where it affects transcription of genes specific for the BMP pathway.
BMPs are unique in their ability to initiate bone formation [16]. Besides inducing bone and cartilage formation, BMPs have been shown to play important roles in the regulation of various cellular processes, including cell proliferation, differentiation, cell motility, apoptosis, and self-renewal of embryonic stem cells [17,18]. BMPs are also known to crosstalk with other major signaling pathways, such as Wnt, JAK/STAT, and Notch [19-22]. BMPs also play roles in the formation and development of multiple of key steps in vertebrate nervous system [23].
BMPs are a wide range of adjustment factors in life processes, and involved in cell proliferation, differentiation, apoptosis and morphogenesis. Some studies have confirmed that BMPs and their associated signaling molecules are closely related to the development in ENS [24]. Recent evidence showed that the low concentration of BMP2 elevated the neurons; on the other hand, at high concentration it limited the number of enteric neurons. Thus, the concentration-related abilities of BMPs to promote neuronal differentiation and reduce the size of the total population of crest-derived cells are consistent with the idea that, by inducing neuronal precursors to differentiate into postmitotic neurons, BMPs limit precursor proliferation in the gut and thus regulate the ultimate size of the ENS [25]. Based on this role of BMPS in ENS development, some researchers found that BMP2 and receptor were strongly and specifically expressed in the gut from patients with HSCR, intestinal neuronal dysplasia, and immature ganglion cells [26].
Our studies here found, for the first time, that BMP2, BMP5 and BMP10 were significantly increased in the stenotic segments of HSCR compared to that in the normal segments, suggesting that these proteins could play important roles in the development of HSCR. The molecular study of endogenous BMP modulators is important for the understanding of mechanism in HSCR. Further studies on their mechanistic pathways may yield new therapeutic targets for HSCR.
Acknowledgements
This work was supported by grant from the National Natural Science Foundation of China (No. 30772277). The authors are grateful to Prof Zhibo Zhang of the Department of Pediatric Surgery, Shengjing Hospital Affiliated to China Medical University for their expert technical assistance. The authors are grateful to Prof Sheng Xiao of the Faculty member of American Board of Medical Genetis Training Program at Harvard Medical School/Department of Pathology Brigham and Women’s Hospital.
Disclosure of conflict of interest
The authors declare no conflict of interest.
References
- 1.Haricharan RN, Georgeson KE. Hirschsprung disease. Semin Pediatr Surg. 2008;17:266–75. doi: 10.1053/j.sempedsurg.2008.07.005. [DOI] [PubMed] [Google Scholar]
- 2.Martucciello G. Hirschsprung’s disease, one of the most difficult diagnoses in pediatric surgery a review of the problems from clinical practice to the bench. Eur J Pediatr Surg. 2008;18:140–149. doi: 10.1055/s-2008-1038625. [DOI] [PubMed] [Google Scholar]
- 3.Phillips RJ, Powley TL. Innervation of the gastrointestinal tract: patterns of aging. Auton Neurosci. 2007;136:1–19. doi: 10.1016/j.autneu.2007.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sánchez-Mejías A, Núñez-Torres R, Fernández RM, Antiñolo G, Borrego S. Novel MLPA procedure using self-designed probes allows comprehensive analysis for CNVs of the genes involved in Hirschsprung disease. BMC Med Genet. 2001;11:71. doi: 10.1186/1471-2350-11-71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Amiel J, Lyonnet S. Hirschsprung disease, associated syndromes, and genetics: a review. J Med Genet. 2001;38:729–739. doi: 10.1136/jmg.38.11.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Fu M, Vohra BP, Wind D, Heuckeroth RO. BMP signaling regulates murine enteric nervous system precursor migration, neurite fasciculation, and patterning via altered Ncam1 polysialic acid addition. Dev Biol. 2006;299:137–50. doi: 10.1016/j.ydbio.2006.07.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kosinski C, Li VS, Chan AS, Zhang J, Ho C, Tsui WY, Chan TL, Mifflin RC, Powell DW, Yuen ST, Leung SY, Chen X. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci U S A. 2007;104:15418–15423. doi: 10.1073/pnas.0707210104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Passarge E. Dissecting Hirschsprung disease. Nat Genet. 2002;31:11–12. doi: 10.1038/ng878. [DOI] [PubMed] [Google Scholar]
- 9.Simic P, Vukicevic S. Bone morphogenetic proteins in development and homeostasis of kidney. Cytokine Growth Factor Rev. 2005;16:299–308. doi: 10.1016/j.cytogfr.2005.02.010. [DOI] [PubMed] [Google Scholar]
- 10.Schmierer B, Hill CS. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol. 2007;8:970–82. doi: 10.1038/nrm2297. [DOI] [PubMed] [Google Scholar]
- 11.Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 1994;8:133–146. doi: 10.1101/gad.8.2.133. [DOI] [PubMed] [Google Scholar]
- 12.Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol. 1998;16:247–52. doi: 10.1038/nbt0398-247. [DOI] [PubMed] [Google Scholar]
- 13.Ducy P, Karsenty G. The family of bone morphogenetic proteins. Kidney Int. 2000;57:2207–14. doi: 10.1046/j.1523-1755.2000.00081.x. [DOI] [PubMed] [Google Scholar]
- 14.Sebald W, Nickel J, Zhang JL, Mueller TD. Molecular recognition in bone morphogenetic protein (BMP) receptor interaction. Biol Chem. 2004;385:697–710. doi: 10.1515/BC.2004.086. [DOI] [PubMed] [Google Scholar]
- 15.Miyazono K, Kusanagi K, Inoue H. Divergence and convergence of TGFbeta/ BMP signaling. J Cell Physiol. 2001;187:265–276. doi: 10.1002/jcp.1080. [DOI] [PubMed] [Google Scholar]
- 16.Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res. 1998;346:26–37. [PubMed] [Google Scholar]
- 17.von Bubnoff A, Cho KW. Intracellular BMP signaling regulation in vertebrates: pathway or network? Dev Biol. 2001;239:1–14. doi: 10.1006/dbio.2001.0388. [DOI] [PubMed] [Google Scholar]
- 18.Hardwick JC, Van Den Brink GR, Bleuming SA, Ballester I, Van Den Brande JM, Keller JJ, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP. Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology. 2004;126:111–121. doi: 10.1053/j.gastro.2003.10.067. [DOI] [PubMed] [Google Scholar]
- 19.Attisano L, Labbé E. TGFbeta and Wnt pathway cross-talk. Cancer Metastasis Rev. 2004;23:53–61. doi: 10.1023/a:1025811012690. [DOI] [PubMed] [Google Scholar]
- 20.Nohe A, Keating E, Knaus P, Petersen NO. Signal transduction of bone morphogenetic protein receptors. Cell Signal. 2004;16:291–9. doi: 10.1016/j.cellsig.2003.08.011. [DOI] [PubMed] [Google Scholar]
- 21.Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 2005;16:251–63. doi: 10.1016/j.cytogfr.2005.01.009. [DOI] [PubMed] [Google Scholar]
- 22.Herpin A, Cunningham C. Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes. FEBS J. 2007;274:2977–85. doi: 10.1111/j.1742-4658.2007.05840.x. [DOI] [PubMed] [Google Scholar]
- 23.Jeong J, Kang DI, Lee GT, Kim IY. Bone Morphogenetic Protein Signaling: Implications in Urology. Korean J Urol. 2010;51:511–517. doi: 10.4111/kju.2010.51.8.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Chalazonitis A, Kessler JA. Pleiotropic effects of the bone morphogenetic proteins on development of the enteric nervous system. Dev Neurobiol. 2012;72:843–56. doi: 10.1002/dneu.22002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Chalazonitis A, D’Autréaux F, Guha U, Pham TD, Faure C, Chen JJ, Roman D, Kan L, Rothman TP, Kessler JA, Gershon MD. Bone Morphogenetic Protein-2 and -4 Limit the Number of Enteric Neurons But Promote Development of a TrkCExpressing Neurotrophin-3-Dependent Subset. J Neurosci. 2004;24:4266–82. doi: 10.1523/JNEUROSCI.3688-03.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Brewer KC, Mwizerva O, Goldstein AM. BMPRIA is a promising marker for evaluating ganglion cells in the enteric nervous system--a pilot study. Hum Pathol. 2005;36:1120–6. doi: 10.1016/j.humpath.2005.08.006. [DOI] [PubMed] [Google Scholar]